Recall

Australia's alfalfa sprout consumers face a health alert following a national recall initiated by Parilla Fresh due to possible Salmonella contamination. The recall comes...

Laboratoire Aguettant has encountered a setback in its journey to bring Hydrocortisone Aguettant to the market for the prevention of bronchopulmonary dysplasia (BPD) in...

The European Medicines Agency (EMA) announces a significant update: the supply shortage of Fasturtec, a critical medication for hyperuricemia, has been successfully resolved. This...

Osurnia, a veterinary medicine containing terbinafine, florfenicol, and betamethasone acetate, is authorized for use within the European Union. Known for its role in treating...

Safety remains a top priority for drug monitoring agencies globally, and the European Union (EU) sits at the forefront of this vigilance. Recently, the...

The European Medicines Agency (EMA) continues to prioritize pharmaceutical safety by meticulously evaluating periodic safety update reports (PSURs) for authorized medicines. This rigorous evaluation...

The withdrawal of a variation application for the veterinary medicine Sileo captured attention, signaling pivotal business decisions within the pharmaceutical landscape. Orion Corporation, which...

The ever-evolving landscape of medication safety takes another critical turn as the Pharmacovigilance Risk Assessment Committee (PRAC) unveiled pivotal evaluations and recommendations in its...

Addressing the urgent demand from America's agricultural community, the FDA has conditionally authorized a groundbreaking solution against New World screwworm infestations in cattle. This...

In an era bustling with advancements in human medicine, the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) plays a crucial role in...

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is set for a pivotal meeting from September 29 to October 2, 2025, in Amsterdam,...

The European Union is grappling with an ongoing scarcity of human normal immunoglobulins, a critical therapeutic element essential for treating a wide array of...

In a recent development affecting the pharmaceuticals landscape in the European Union, the European Commission has officially withdrawn the marketing authorization for Grastofil, a...

The European Medicines Agency has orchestrated a comprehensive review of omega-3-acid ethyl esters 90, a widely used substance in several EU-authorized medicinal products. This...

In the realm of public health, keeping healthcare professionals informed about the latest developments is critical. Recent updates about the chikungunya vaccine, Ixchiq, present...